Peregrine Ventures
Global life science venture capital fund investing in medical innovation from seed to growth stages.
About
Peregrine Ventures is a leading global life science venture capital fund focused on advancing medical innovation. They invest across the entire corporate lifecycle, from pre-seed incubation through growth stages, with a particular emphasis on medical devices, pharmaceuticals, biotech, and digital health. Their strategy involves providing strategic investments and expert guidance to help companies bring groundbreaking medical technologies to market.
Key facts
- Website
- peregrinevc.com
- Type
- VC
- Headquarters
- Or Yehuda, Israel
- Funds raised
- $600M
- Portfolio companies
- 39
- Stages
- Pre-SeedSeedSeries ASeries BSeries C
- Cheque size
- $586K to $105M
- Sector focus
- SpeechHealthcareVoice AnalysisHeart FailureMonitoring
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 28 Jan 2025 | Lutris Pharma | Series A | $30M |
| 6 May 2024 | Nectin Therapeutics | Series C | $10M |
| 28 Feb 2024 | Nectin Therapeutics | Grant | $3M |
| 23 Jan 2024 | Bluewhite | Series C | $39M |
| 20 Nov 2023 | Kanso Diagnostics | Seed | Undisclosed |
| 18 Oct 2023 | Variantyx | Series D | Undisclosed |
| 9 Oct 2023 | Wanda Fish | Seed | $7M |
| 30 Jul 2023 | xFind.ai | Pre-Seed | $3M |
| 1 Jun 2023 | Mush Foods | Seed | $12M |
| 24 Jan 2023 | Forsea | Seed | $16M |
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
What companies has Peregrine Ventures invested in?
Peregrine Ventures has invested in Lutris Pharma, Nectin Therapeutics, Bluewhite, Kanso Diagnostics, Variantyx and 34 more.
SEC filings, insider activity, nonprofit links and pay benchmarks for Peregrine Ventures:
